nodes	percent_of_prediction	percent_of_DWPC	metapath
Etoposide—ABCC3—Rifampicin—leprosy	0.131	0.145	CbGbCtD
Etoposide—UGT1A1—Rifampicin—leprosy	0.0981	0.108	CbGbCtD
Etoposide—ABCC1—Rifampicin—leprosy	0.0807	0.089	CbGbCtD
Etoposide—PTGS2—Thalidomide—leprosy	0.0609	0.0672	CbGbCtD
Etoposide—ABCC2—Rifampicin—leprosy	0.0597	0.0659	CbGbCtD
Etoposide—PTGS1—Thalidomide—leprosy	0.0514	0.0568	CbGbCtD
Etoposide—PTGS2—Dapsone—leprosy	0.0487	0.0538	CbGbCtD
Etoposide—PTGS1—Dapsone—leprosy	0.0411	0.0454	CbGbCtD
Etoposide—CYP2E1—Thalidomide—leprosy	0.0397	0.0439	CbGbCtD
Etoposide—CYP2E1—Rifampicin—leprosy	0.0385	0.0425	CbGbCtD
Etoposide—CYP2E1—Dapsone—leprosy	0.0318	0.0351	CbGbCtD
Etoposide—CYP3A5—Thalidomide—leprosy	0.0309	0.0341	CbGbCtD
Etoposide—CYP3A5—Rifampicin—leprosy	0.0299	0.033	CbGbCtD
Etoposide—CYP2C8—Rifampicin—leprosy	0.0288	0.0317	CbGbCtD
Etoposide—CYP3A5—Dapsone—leprosy	0.0247	0.0272	CbGbCtD
Etoposide—CYP2C8—Dapsone—leprosy	0.0237	0.0262	CbGbCtD
Etoposide—CYP1A2—Thalidomide—leprosy	0.023	0.0254	CbGbCtD
Etoposide—CYP1A2—Rifampicin—leprosy	0.0223	0.0246	CbGbCtD
Etoposide—ABCB1—Rifampicin—leprosy	0.0195	0.0215	CbGbCtD
Etoposide—CYP3A4—Rifampicin—leprosy	0.0117	0.0129	CbGbCtD
Etoposide—CYP3A4—Dapsone—leprosy	0.00963	0.0106	CbGbCtD
Etoposide—TOP2B—Menadione—Thalidomide—leprosy	0.00383	0.861	CbGdCrCtD
Etoposide—Acute leukaemia—Thalidomide—leprosy	0.00357	0.0469	CcSEcCtD
Etoposide—Septic shock—Thalidomide—leprosy	0.00338	0.0443	CcSEcCtD
Etoposide—Skin necrosis—Thalidomide—leprosy	0.00292	0.0383	CcSEcCtD
Etoposide—Ascites—Thalidomide—leprosy	0.00225	0.0295	CcSEcCtD
Etoposide—Skin exfoliation—Dapsone—leprosy	0.0019	0.025	CcSEcCtD
Etoposide—Febrile neutropenia—Thalidomide—leprosy	0.0017	0.0223	CcSEcCtD
Etoposide—Nail disorder—Thalidomide—leprosy	0.00157	0.0206	CcSEcCtD
Etoposide—Interstitial lung disease—Thalidomide—leprosy	0.00144	0.0189	CcSEcCtD
Etoposide—Cyanosis—Thalidomide—leprosy	0.00144	0.0189	CcSEcCtD
Etoposide—Tingling sensation—Thalidomide—leprosy	0.00127	0.0167	CcSEcCtD
Etoposide—Numbness—Thalidomide—leprosy	0.00123	0.0162	CcSEcCtD
Etoposide—Apnoea—Thalidomide—leprosy	0.0012	0.0158	CcSEcCtD
Etoposide—Sensory loss—Thalidomide—leprosy	0.00118	0.0155	CcSEcCtD
Etoposide—Skin discolouration—Thalidomide—leprosy	0.00113	0.0148	CcSEcCtD
Etoposide—Cellulitis—Thalidomide—leprosy	0.00112	0.0147	CcSEcCtD
Etoposide—Hyperuricaemia—Thalidomide—leprosy	0.0011	0.0144	CcSEcCtD
Etoposide—Neuropathy peripheral—Dapsone—leprosy	0.00109	0.0143	CcSEcCtD
Etoposide—Blood uric acid increased—Thalidomide—leprosy	0.00104	0.0136	CcSEcCtD
Etoposide—Phosphatase alkaline increased—Thalidomide—leprosy	0.00102	0.0134	CcSEcCtD
Etoposide—Candida infection—Thalidomide—leprosy	0.000975	0.0128	CcSEcCtD
Etoposide—Skin exfoliation—Thalidomide—leprosy	0.000975	0.0128	CcSEcCtD
Etoposide—Neuropathy—Thalidomide—leprosy	0.000959	0.0126	CcSEcCtD
Etoposide—Oesophagitis—Thalidomide—leprosy	0.000933	0.0122	CcSEcCtD
Etoposide—Rash maculo-papular—Thalidomide—leprosy	0.000928	0.0122	CcSEcCtD
Etoposide—Sepsis—Thalidomide—leprosy	0.000886	0.0116	CcSEcCtD
Etoposide—PTGS2—hindlimb—leprosy	0.000874	0.0659	CbGeAlD
Etoposide—Blood alkaline phosphatase increased—Thalidomide—leprosy	0.000852	0.0112	CcSEcCtD
Etoposide—ABCC6—eye—leprosy	0.000838	0.0632	CbGeAlD
Etoposide—Cardiac failure congestive—Thalidomide—leprosy	0.000817	0.0107	CcSEcCtD
Etoposide—Vertigo—Dapsone—leprosy	0.000783	0.0103	CcSEcCtD
Etoposide—Cough—Dapsone—leprosy	0.000761	0.00998	CcSEcCtD
Etoposide—TOP2B—eye—leprosy	0.00076	0.0573	CbGeAlD
Etoposide—Cardiac failure—Thalidomide—leprosy	0.00076	0.00996	CcSEcCtD
Etoposide—PTGS2—appendage—leprosy	0.00075	0.0565	CbGeAlD
Etoposide—Cardiac arrest—Thalidomide—leprosy	0.000705	0.00924	CcSEcCtD
Etoposide—Tachycardia—Dapsone—leprosy	0.000695	0.00911	CcSEcCtD
Etoposide—Toxic epidermal necrolysis—Thalidomide—leprosy	0.000667	0.00875	CcSEcCtD
Etoposide—Cramp muscle—Thalidomide—leprosy	0.000667	0.00875	CcSEcCtD
Etoposide—Alanine aminotransferase increased—Thalidomide—leprosy	0.000654	0.00857	CcSEcCtD
Etoposide—Dysphagia—Thalidomide—leprosy	0.000641	0.0084	CcSEcCtD
Etoposide—Bronchospasm—Thalidomide—leprosy	0.00063	0.00826	CcSEcCtD
Etoposide—PTGS2—skin epidermis—leprosy	0.000624	0.047	CbGeAlD
Etoposide—TOP2A—Menadione—Thalidomide—leprosy	0.000619	0.139	CbGdCrCtD
Etoposide—Pancytopenia—Thalidomide—leprosy	0.000608	0.00798	CcSEcCtD
Etoposide—Neutropenia—Thalidomide—leprosy	0.000599	0.00786	CcSEcCtD
Etoposide—Gastrointestinal pain—Dapsone—leprosy	0.000582	0.00763	CcSEcCtD
Etoposide—Pneumonia—Thalidomide—leprosy	0.000575	0.00753	CcSEcCtD
Etoposide—Infestation NOS—Thalidomide—leprosy	0.000571	0.00749	CcSEcCtD
Etoposide—Infestation—Thalidomide—leprosy	0.000571	0.00749	CcSEcCtD
Etoposide—Stevens-Johnson syndrome—Thalidomide—leprosy	0.000566	0.00743	CcSEcCtD
Etoposide—Acute coronary syndrome—Thalidomide—leprosy	0.000563	0.00738	CcSEcCtD
Etoposide—Body temperature increased—Dapsone—leprosy	0.000563	0.00738	CcSEcCtD
Etoposide—Abdominal pain—Dapsone—leprosy	0.000563	0.00738	CcSEcCtD
Etoposide—Renal failure—Thalidomide—leprosy	0.000562	0.00736	CcSEcCtD
Etoposide—Myocardial infarction—Thalidomide—leprosy	0.00056	0.00734	CcSEcCtD
Etoposide—Neuropathy peripheral—Thalidomide—leprosy	0.00056	0.00734	CcSEcCtD
Etoposide—Stomatitis—Thalidomide—leprosy	0.000557	0.0073	CcSEcCtD
Etoposide—GSTT1—nervous system—leprosy	0.000556	0.0419	CbGeAlD
Etoposide—Agranulocytosis—Thalidomide—leprosy	0.000533	0.00699	CcSEcCtD
Etoposide—Hypoaesthesia—Thalidomide—leprosy	0.00051	0.00669	CcSEcCtD
Etoposide—Urinary tract disorder—Thalidomide—leprosy	0.000506	0.00664	CcSEcCtD
Etoposide—TOP2B—tendon—leprosy	0.000504	0.038	CbGeAlD
Etoposide—Urethral disorder—Thalidomide—leprosy	0.000503	0.00659	CcSEcCtD
Etoposide—Erythema multiforme—Thalidomide—leprosy	0.000485	0.00636	CcSEcCtD
Etoposide—Eye disorder—Thalidomide—leprosy	0.000479	0.00628	CcSEcCtD
Etoposide—GSTP1—eye—leprosy	0.000476	0.0359	CbGeAlD
Etoposide—Cardiac disorder—Thalidomide—leprosy	0.000476	0.00624	CcSEcCtD
Etoposide—Angiopathy—Thalidomide—leprosy	0.000465	0.0061	CcSEcCtD
Etoposide—Immune system disorder—Thalidomide—leprosy	0.000463	0.00607	CcSEcCtD
Etoposide—Mediastinal disorder—Thalidomide—leprosy	0.000462	0.00606	CcSEcCtD
Etoposide—Chills—Thalidomide—leprosy	0.00046	0.00603	CcSEcCtD
Etoposide—Alopecia—Thalidomide—leprosy	0.000453	0.00594	CcSEcCtD
Etoposide—Vomiting—Dapsone—leprosy	0.000452	0.00593	CcSEcCtD
Etoposide—Headache—Dapsone—leprosy	0.000446	0.00585	CcSEcCtD
Etoposide—Dysgeusia—Thalidomide—leprosy	0.000437	0.00573	CcSEcCtD
Etoposide—PTGS1—blood vessel—leprosy	0.000437	0.0329	CbGeAlD
Etoposide—Back pain—Thalidomide—leprosy	0.000432	0.00566	CcSEcCtD
Etoposide—Muscle spasms—Thalidomide—leprosy	0.000429	0.00563	CcSEcCtD
Etoposide—Nausea—Dapsone—leprosy	0.000423	0.00554	CcSEcCtD
Etoposide—PTGS2—blood vessel—leprosy	0.000418	0.0315	CbGeAlD
Etoposide—TOP2B—testis—leprosy	0.000417	0.0314	CbGeAlD
Etoposide—GSTP1—skin of body—leprosy	0.000414	0.0312	CbGeAlD
Etoposide—Ill-defined disorder—Thalidomide—leprosy	0.000414	0.00543	CcSEcCtD
Etoposide—Anaemia—Thalidomide—leprosy	0.000413	0.00541	CcSEcCtD
Etoposide—TOP2B—nervous system—leprosy	0.000409	0.0308	CbGeAlD
Etoposide—Malaise—Thalidomide—leprosy	0.000403	0.00528	CcSEcCtD
Etoposide—Vertigo—Thalidomide—leprosy	0.000401	0.00526	CcSEcCtD
Etoposide—Leukopenia—Thalidomide—leprosy	0.0004	0.00524	CcSEcCtD
Etoposide—Loss of consciousness—Thalidomide—leprosy	0.000392	0.00515	CcSEcCtD
Etoposide—Cough—Thalidomide—leprosy	0.00039	0.00511	CcSEcCtD
Etoposide—Convulsion—Thalidomide—leprosy	0.000387	0.00507	CcSEcCtD
Etoposide—Hypertension—Thalidomide—leprosy	0.000385	0.00505	CcSEcCtD
Etoposide—Chest pain—Thalidomide—leprosy	0.00038	0.00498	CcSEcCtD
Etoposide—Unspecified disorder of skin and subcutaneous tissue—Thalidomide—leprosy	0.000377	0.00495	CcSEcCtD
Etoposide—Discomfort—Thalidomide—leprosy	0.000375	0.00492	CcSEcCtD
Etoposide—TOP2A—tendon—leprosy	0.00037	0.0279	CbGeAlD
Etoposide—Confusional state—Thalidomide—leprosy	0.000367	0.00482	CcSEcCtD
Etoposide—Infection—Thalidomide—leprosy	0.000362	0.00475	CcSEcCtD
Etoposide—Thrombocytopenia—Thalidomide—leprosy	0.000357	0.00468	CcSEcCtD
Etoposide—Tachycardia—Thalidomide—leprosy	0.000356	0.00466	CcSEcCtD
Etoposide—Skin disorder—Thalidomide—leprosy	0.000354	0.00464	CcSEcCtD
Etoposide—Hyperhidrosis—Thalidomide—leprosy	0.000352	0.00462	CcSEcCtD
Etoposide—Anorexia—Thalidomide—leprosy	0.000347	0.00455	CcSEcCtD
Etoposide—Hypotension—Thalidomide—leprosy	0.00034	0.00446	CcSEcCtD
Etoposide—Paraesthesia—Thalidomide—leprosy	0.000327	0.00429	CcSEcCtD
Etoposide—Dyspnoea—Thalidomide—leprosy	0.000325	0.00426	CcSEcCtD
Etoposide—Somnolence—Thalidomide—leprosy	0.000324	0.00425	CcSEcCtD
Etoposide—Decreased appetite—Thalidomide—leprosy	0.000317	0.00415	CcSEcCtD
Etoposide—GSTP1—tendon—leprosy	0.000315	0.0238	CbGeAlD
Etoposide—ABCC10—tendon—leprosy	0.000315	0.0238	CbGeAlD
Etoposide—Gastrointestinal disorder—Thalidomide—leprosy	0.000315	0.00412	CcSEcCtD
Etoposide—Fatigue—Thalidomide—leprosy	0.000314	0.00412	CcSEcCtD
Etoposide—Pain—Thalidomide—leprosy	0.000312	0.00409	CcSEcCtD
Etoposide—Constipation—Thalidomide—leprosy	0.000312	0.00409	CcSEcCtD
Etoposide—TOP2A—testis—leprosy	0.000307	0.0231	CbGeAlD
Etoposide—Feeling abnormal—Thalidomide—leprosy	0.0003	0.00394	CcSEcCtD
Etoposide—Gastrointestinal pain—Thalidomide—leprosy	0.000298	0.00391	CcSEcCtD
Etoposide—Urticaria—Thalidomide—leprosy	0.000289	0.0038	CcSEcCtD
Etoposide—Body temperature increased—Thalidomide—leprosy	0.000288	0.00378	CcSEcCtD
Etoposide—Abdominal pain—Thalidomide—leprosy	0.000288	0.00378	CcSEcCtD
Etoposide—Hypersensitivity—Thalidomide—leprosy	0.000268	0.00352	CcSEcCtD
Etoposide—ABCC3—testis—leprosy	0.000262	0.0198	CbGeAlD
Etoposide—Asthenia—Thalidomide—leprosy	0.000261	0.00343	CcSEcCtD
Etoposide—GSTP1—testis—leprosy	0.000261	0.0197	CbGeAlD
Etoposide—ABCC10—testis—leprosy	0.000261	0.0197	CbGeAlD
Etoposide—ABCB1—blood vessel—leprosy	0.000258	0.0195	CbGeAlD
Etoposide—Pruritus—Thalidomide—leprosy	0.000258	0.00338	CcSEcCtD
Etoposide—ABCC3—nervous system—leprosy	0.000257	0.0194	CbGeAlD
Etoposide—GSTP1—nervous system—leprosy	0.000256	0.0193	CbGeAlD
Etoposide—ABCC2—tendon—leprosy	0.000253	0.0191	CbGeAlD
Etoposide—Diarrhoea—Thalidomide—leprosy	0.000249	0.00327	CcSEcCtD
Etoposide—Dizziness—Thalidomide—leprosy	0.000241	0.00316	CcSEcCtD
Etoposide—Vomiting—Thalidomide—leprosy	0.000232	0.00304	CcSEcCtD
Etoposide—Rash—Thalidomide—leprosy	0.00023	0.00301	CcSEcCtD
Etoposide—Dermatitis—Thalidomide—leprosy	0.000229	0.00301	CcSEcCtD
Etoposide—Headache—Thalidomide—leprosy	0.000228	0.00299	CcSEcCtD
Etoposide—ABCC1—tendon—leprosy	0.000223	0.0168	CbGeAlD
Etoposide—Nausea—Thalidomide—leprosy	0.000216	0.00284	CcSEcCtD
Etoposide—ABCC2—testis—leprosy	0.00021	0.0158	CbGeAlD
Etoposide—PTGS1—skin of body—leprosy	0.000202	0.0152	CbGeAlD
Etoposide—PTGS2—skin of body—leprosy	0.000193	0.0146	CbGeAlD
Etoposide—ABCC1—testis—leprosy	0.000185	0.0139	CbGeAlD
Etoposide—CYP2E1—tendon—leprosy	0.00016	0.012	CbGeAlD
Etoposide—CYP2C8—testis—leprosy	0.000157	0.0118	CbGeAlD
Etoposide—PTGS1—tendon—leprosy	0.000154	0.0116	CbGeAlD
Etoposide—ABCG2—testis—leprosy	0.000153	0.0115	CbGeAlD
Etoposide—PTGS2—tendon—leprosy	0.000147	0.0111	CbGeAlD
Etoposide—CYP2E1—testis—leprosy	0.000132	0.00997	CbGeAlD
Etoposide—CYP2E1—nervous system—leprosy	0.00013	0.00979	CbGeAlD
Etoposide—PTGS1—testis—leprosy	0.000127	0.00961	CbGeAlD
Etoposide—PTGS1—nervous system—leprosy	0.000125	0.00943	CbGeAlD
Etoposide—PTGS2—nervous system—leprosy	0.00012	0.00901	CbGeAlD
Etoposide—CYP3A4—nervous system—leprosy	0.000104	0.00788	CbGeAlD
Etoposide—ABCB1—testis—leprosy	7.54e-05	0.00568	CbGeAlD
Etoposide—ABCB1—nervous system—leprosy	7.4e-05	0.00558	CbGeAlD
